Back to results
US 6,727,347 B1Granted
Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body
OwnerPeter Szegoinventor
Life of this patent
Estimating the term…
Abstract
Polycation bioconjugates and a method for producing them. The polycations are capable of transporting active substances of different types. The polycations function as carrier molecules that transport enhancer molecules, thereby enhancing the biological effectiveness of the transported molecules. The polycation bioconjugates of the present invention may inhibit malignant cell proliferation, possess antimicrobial effect, or be configured for gene transport.
Claims20
A polycation bioconjugate, comprising:
- one or more carrier molecules having free α-amino groups, and one or more enhancer or connecting molecules, wherein the polycation bioconjugate has the general formula (I)
- wherein
- “r” is a mean value between 20 and 400 that designates the number of diaminomonocarbonic acyl group monomers;
- “m”=0, 1, 2, 3, . . . ;
- [(k)Mx] designates enhancer molecules and/or connecting molecules linked by covalent (═k) bonds to a carrier molecule;
- [(i)Mx] designates enhancer molecules linked by ionic (═i) bonds to a carrier molecule, wherein the Mx functional groups may be the same or different, and the enhancer molecules can be linked directly and/or indirectly, through a connecting molecule, to the carrier molecule, and wherein when both [(k)Mx] and [(i)Mx] occur within the same polycation bioconjugate [(i)Mx]*[(k)Mx] is symbolized by [(k/i)Mx];
- the carrier molecules are of the same configuration (either D- or L-), and the individual monomers are not linked together by their amino groups in the α-positions, and are linked together by amino groups in other positions according to the value of m, wherein the carrier molecules have a general formula (I/a):
- wherein [(k)Mx]=[(−)Cxj]p2 and at least one carrier molecule is linked with one or more connecting molecules [(−)Cxj] of anionic character, wherein the Cxj molecules may be the same or different, and are selected from the group consisting of dicarbonic acids, tricarbonic acids, carbohydrates, amino acids, and peptide chain elongators;
- wherein
- “(−)Cx” in “[(−)Cxj]p2” designates (−)Cx connecting molecules of anionic character of different (“x”) kind linked to at least one carrier molecule of general formula (I/a) by covalent bonds;
- “j” indicates whether the (−)Cx connecting molecules are identical (j=1) or different according to the number “j” (j=2, 3, . . . );
- and
- “p2” indicates a degree of saturation in % of a carrier molecule of general formula (I/a) by [(−)Cxj] connecting molecules of exclusively anionic character, p2 having a value which is >0 and ≦100.
10 more elements
A polycation bioconjugate, comprising:
- one or more carrier molecules having free α-amino groups, and one or more enhancer or connecting molecules, wherein the polycation bioconjugate has the general formula (I)
- wherein
- “r” is a mean value between 20 and 400 that designates the number of diaminomonocarbonic acyl group monomers;
- “m”=0, 1, 2, 3, . . . ;
- [(k)Mx] designates enhancer molecules and/or connecting molecules linked by covalent (═k) bonds to a carrier molecule;
- [(i)Mx] designates enhancer molecules linked by ionic (═i) bonds to a carrier molecule, wherein the Mx functional groups may be the same or different, and the enhancer molecules can be linked directly and/or indirectly, through a connecting molecule, to the carrier molecule, and wherein when both [(k)Mx] and [(i)Mx] occur within the same polycation bioconjugate [(i)Mx]*[(k)Mx] is symbolized by [(k/i)Mx];
- the carrier molecules are of the same configuration (either D- or L-), and the individual monomers are not linked together by their amino groups in the α-positions, and are linked together by amino groups in other positions according to the value of m, wherein the carrier molecules have a general formula (I/a):
- wherein [(k)Mx]=
- [Exi]p1 and/or
- [(−)Cxj]p2 and/or
- [Cxck−Exek]p3
- and at least one carrier molecule is linked with at least two of [Exi]p1, [(−)Cxj]p2 and [Cxck−Exek]p3, such that [(k)Mx]=
- [Exi]p1+[(−)Cxj]p2 or
- [Exi]p1+[Cxck−Exek]p3 or
- [Cxck−Exek]p3+[(−)Cxj]p2 or
- [Exi]p1+[Cxck−Exek]p3+[(−)Cxj]p2, wherein
- “Ex” in “[Exi]p1” designates the Ex enhancer molecules of different (“x”) kind linked to at least one carrier molecule of general formula (I/a) by covalent bonds;
- “i” indicates whether the Ex enhancer molecules are identical ones (i=1) or different according to the number “i” (i=2, 3, . . . );
- “pi” indicates a degree of saturation in % of a carrier molecule of general formula (I/a) by [Exi] enhancer molecules;
- “(−)Cx” in “[(−)Cxj]p2” designates (−)Cx connecting molecules of anionic character of different (“x”) kind linked to at least one carrier molecule of general formula (I/a) by covalent bonds;
- “j” indicates whether the (−)Cx connecting molecules are identical (j=1) or different according to the number “j” (j=2, 3, . . . );
- “p2” indicates a degree of saturation in % of a carrier molecule of general formula (I/a) by [(−)Cxj] connecting molecules of exclusively anionic character;
- “Cx−Ex” in “[Cxck−Exek]p3” designates the Ex enhancer molecules of different (“x”) kind linked to at least one carrier molecule of general formula (I/a) by covalent bonds indirectly through Cx connecting molecules of different (“x”) kind linked to at least one carrier molecule of general formula (I/a);
- “ck” indicates whether the Cx connecting molecules are identical (ck=1) or of different kind (ck=2, 3, . . . );
- “ek” indicates whether the Ex enhancer molecules are identical (ek=1) or of different kind (ek=2, 3, . . . );
- “p3” indicates a degree of saturation in % of a carrier molecule of general formula (I/a) by [Exek] enhancer molecules linked indirectly to Cxck connecting molecules;
- “p1”+“p2”+“p3” is >0 and ≦100, and at least two of “p1,” “p2” and “p3” are greater than 0;
- and
- the Ex molecules in [Exi] and the (−)Cx molecules in [(−)Cxj] are the same or different than the Ex and Cx molecules in [Cxck−Exek].
26 more elements
A polycation bioconjugate, comprising:
- one or more carrier molecules having free α-aiming groups, and one or more enhancer or connecting molecules, wherein the polycation bioconjugate has the general formula (I)
- wherein
- “r” is a mean value between 20 and 400 that designates the number of diaminomonocarbonic acyl group monomers;
- “m”=0, 1, 2, 3, . . . ;
- [(k)Mx] designates enhancer molecules and/or connecting molecules linked by covalent (═k) bonds to a carrier molecule;
- [(i)Mx] designates enhancer molecules linked by ionic (═i) bonds to a carrier molecule, wherein the Mx functional groups may be the same or different, and the enhancer molecules can be linked directly and/or indirectly, through a connecting molecule, to the carrier molecule, and wherein when both [(k)Mx] and [(i)Mx] occur within the same polycation bioconjugate [(i)Mx]*[(k)Mx] is symbolized by [(k/i)Mx];
- the carrier molecules are of the same configuration (either D- or L-), and the individual monomers are not linked together by their amino groups in the α-positions, and are linked together by amino groups in other positions according to the value of m, wherein the carrier molecules have a general formula (I/a):
- wherein [(i)Mx]=[(−)Axs]t and at least one carrier molecule is linked with one or more enhancer molecules [(−)Axs] of anionic character, wherein the Ax, molecules may be the same or different, wherein
- “Ax” in “[(−)Axs]t” designates the (−)Ax enhancer molecules of anionic character of same or different (“x”) kind linked to at least one carrier molecule of general formula (I/a) by ionic bonds;
- “s” indicates whether the Ax enhancer molecules are identical (s=1) or of different kind (s=2, 3, . . . );
- and
- “t” indicates a degree of saturation in % of a carrier molecule of general formula (I/a) by [(−)Axs] enhancer molecules, t having a value which is >0 and ≦100.
9 more elements
A polycation bioconjugate, comprising:
- one or more carrier molecules having free α-amino groups, and one or more enhancer or connecting molecules, wherein the polycation bioconjugate has the general formula (I)
- wherein
- “r” is a mean value between 20 and 400 that designates the number of diaminomonocarbonic acyl group monomers;
- “m”=0, 1, 2, 3, . . . ;
- [(k)Mx] designates enhancer molecules and/or connecting molecules linked by covalent (═k) bonds to a carrier molecule;
- [(i)Mx] designates enhancer molecules linked by ionic (═i) bonds to a carrier molecule, wherein the Mx functional groups may be the same or different, and the enhancer molecules can be linked directly and/or indirectly, through a connecting molecule, to the carrier molecule, and wherein when both [(k)Mx] and [(i)Mx] occur within the same polycation bioconjugate [(i)Mx]*[(k)Mx] is symbolized by [(k/i)Mx];
- and a nucleic acid linked by an ionic bond to at least one carrier molecule.
4 more elements
Dependencies are inferred from the claim text.